These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9649134)
41. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours. Evans MF; McDicken IW; Herrington CS J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488 [TBL] [Abstract][Full Text] [Related]
42. [Serous and mucinous epithelial ovarian tumors--a clinicopathologic study of 116 cases]. Giurgea NL; Pitrop M; Mihailovici MS Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):389-94. PubMed ID: 23077925 [TBL] [Abstract][Full Text] [Related]
44. Macrophages and microvessel density in tumors of the ovary. Orre M; Rogers PA Gynecol Oncol; 1999 Apr; 73(1):47-50. PubMed ID: 10094879 [TBL] [Abstract][Full Text] [Related]
45. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232 [TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung. Sikora J; Słodkowska J; Radomyski A; Giedronowicz D; Kobos J; Kupis W; Rudzinski P Rocz Akad Med Bialymst; 1997; 42 Suppl 1():271-9. PubMed ID: 9337544 [TBL] [Abstract][Full Text] [Related]
47. Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses. Bais C; Mueller B; Brady MF; Mannel RS; Burger RA; Wei W; Marien KM; Kockx MM; Husain A; Birrer MJ; J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059426 [TBL] [Abstract][Full Text] [Related]
48. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105. Kumagai Y; Sobajima J; Higashi M; Ishiguro T; Fukuchi M; Ishibashi K; Baba H; Mochiki E; Yakabi K; Kawano T; Tamaru J; Ishida H Jpn J Clin Oncol; 2014 Jun; 44(6):526-33. PubMed ID: 24748644 [TBL] [Abstract][Full Text] [Related]
49. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702 [TBL] [Abstract][Full Text] [Related]
50. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome. Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886 [TBL] [Abstract][Full Text] [Related]
51. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V; Cerasoli S; Vitarelli E; Tuccari G Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [TBL] [Abstract][Full Text] [Related]
52. Expression of thymidine phosphorylase in malignant ovarian tumors: correlation with microvessel density and an ultrasound-derived index of angiogenesis. Hata K; Nagami H; Iida K; Miyazaki K; Collins WP Ultrasound Obstet Gynecol; 1998 Sep; 12(3):201-6. PubMed ID: 9793193 [TBL] [Abstract][Full Text] [Related]
53. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors]. Gaggero G; Sola S; Mora M; Fulcheri E Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202 [TBL] [Abstract][Full Text] [Related]
54. DNA Cytometry and Nuclear Morphometry in Ovarian Benign, Borderline and Malignant Tumors. El Din AA; Badawi MA; Aal SE; Ibrahim NA; Morsy FA; Shaffie NM Open Access Maced J Med Sci; 2015 Dec; 3(4):537-44. PubMed ID: 27275284 [TBL] [Abstract][Full Text] [Related]
55. Ovarian cancer p53 mutation is associated with tumor microvessel density. Goodheart MJ; Vasef MA; Sood AK; Davis CS; Buller RE Gynecol Oncol; 2002 Jul; 86(1):85-90. PubMed ID: 12079305 [TBL] [Abstract][Full Text] [Related]
56. Microvessel density and vascular basement membrane immunostaining in tumours of the breast. Orre M; Susil B; Rogers PA Angiogenesis; 1999; 3(2):175-80. PubMed ID: 14517435 [TBL] [Abstract][Full Text] [Related]
57. Neuropilin-1 and VEGF correlate with somatostatin expression and microvessel density in ovarian tumours. Hall GH; Turnbull LW; Bedford K; Richmond I; Helboe L; Atkin SL Int J Oncol; 2005 Nov; 27(5):1283-8. PubMed ID: 16211223 [TBL] [Abstract][Full Text] [Related]